BioCentury | Dec 19, 2019
Finance

Boehringer deal, clinical milestones support Bridge IPO

...IPO, Bridge had raised about $52.9 million in venture financing. According to Jennifer Kim of Shinhan Investment-Private Equity...
BioCentury | Sep 23, 2019
Financial News

Sept. 23 Financial Quick Takes: Innate looks to add U.S. listing; plus Curamir's launch, Qihan Bio and Vedanta

...bringing the total amount raised $62.1 million. New investors including QUAD Investment Management, SV Investment, Shinhan Investment-Private Equity...
BioCentury | Aug 21, 2019
Financial News

Oncorus raises $79.5M series B with eye on global development

...the round, which included fellow new investors Surveyor Capital, Sphera Funds and five Korean firms: Shinhan Investment-Private Equity...
Items per page:
1 - 3 of 3
BioCentury | Dec 19, 2019
Finance

Boehringer deal, clinical milestones support Bridge IPO

...IPO, Bridge had raised about $52.9 million in venture financing. According to Jennifer Kim of Shinhan Investment-Private Equity...
BioCentury | Sep 23, 2019
Financial News

Sept. 23 Financial Quick Takes: Innate looks to add U.S. listing; plus Curamir's launch, Qihan Bio and Vedanta

...bringing the total amount raised $62.1 million. New investors including QUAD Investment Management, SV Investment, Shinhan Investment-Private Equity...
BioCentury | Aug 21, 2019
Financial News

Oncorus raises $79.5M series B with eye on global development

...the round, which included fellow new investors Surveyor Capital, Sphera Funds and five Korean firms: Shinhan Investment-Private Equity...
Items per page:
1 - 3 of 3